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Abstract 
 
Despite the negative results of the international EC-IC bypass study, well-selected 
patients with haemodynamic impairment might benefit from the bypass procedure in 
terms of stroke prevention. This report is about a single centre experience in EC-IC 
bypass procedure. All patients with atherosclerotic occlusive cerebrovascular 
diseases treated by EC-IC bypass surgery were retrospectively reviewed. 
Preoperatively, 61% of patients presented with minor stroke and the remaining 39% 
with recurrent TIAs despite maximal medical therapy. Angiography revealed a 
unilateral ICA stenosis/occlusion in 79%, bilateral ICA stenosis/occlusion in 15%, 
MCA stenosis/occlusion in 3% and other multiple vessel stenosis/occlusion in 3% of 
cases. H215O PET or 99mTc-HMPAO SPECT with acetazolamide challenge was 
performed for haemodynamic evaluation. All patients had impaired haemodynamics 
preoperatively in terms of reduced rCVR and rCBF. Standard STA-MCA bypass was 
performed in all patients. A total of 68 patients with 82 bypasses were reviewed with 
a mean follow-up of 34 month. Overall postoperative stroke occurred in 10 patients 
(15%) resulting in an annual stroke risk of 5%. Improved cerebral haemodynamics 
was documented in 81% of revascularized hemispheres. Patients with unchanged or 
worse haemodynamic parameters had significant more postoperative TIAs or stroke 
(P < 0.05). In conclusion, EC-IC bypass procedure in selected patients with occlusive 
cerebrovascular disease and haemodynamic impairment is useful. Compared to 
earlier described stroke risk in natural history of patients with compromised 
haemodynamics, the current results indicate a risk reduction by EC-IC bypass 
surgery. 
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Introduction 
 
The extracranial-intracranial (EC-IC) bypass was widely used to treat occlusive 
cerebrovascular disease that was not amenable to carotid endarterectomy since its 
introduction in 1967 by Yasargil and Donaghy.1-3 It was the international randomized 
study of EC-IC bypass whose final results in 1985 called the role of the procedure in 
prevention of further recurrent stroke into question. In the latter study, bypass surgery 
failed to be effective in preventing cerebral ischemia, with surgical patients having 
strokes earlier and more frequently than patients receiving best medical treatment.4 
The international EC-IC bypass study was widely accepted, but not without critic.5, 6 
The absence of documented haemodynamic status was one the major flaws in this 
study.7 Despite the failing of the international randomized EC-IC bypass study, some 
neurosurgeons continued to use the EC-IC bypass technique in carefully selected 
cases with primary occlusive cerebrovascular disease.8-13 The fact that a certain 
subgroup of patients with occlusive cerebrovascular disease may benefit from 
bypass procedure in terms of stroke prevention is still controversial.7, 14, 15 The aim of 
this study was to report about the experience and results on EC-IC bypass in patients 
with occlusive cerebrovascular disease at the Department of Neurosurgery, 
University Hospital of Zurich, Switzerland. 
 
 
Clinical material and methods 
 
We retrospectively analyzed all patients with atherosclerotic single or multiple 
vessel occlusive diseases treated with EC-IC bypass operation between 1993 and 
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2007 at the Department of Neurosurgery, University Hospital of Zurich, Switzerland. 
All patients suffered from symptomatic occlusive disease refractory to medical 
treatment. Revascularization procedures for the posterior circulation were not 
analyzed in the current study. Further, patients who underwent EC-IC bypass 
procedure due to therapeutic occlusion of intracranial arteries for unclippable 
aneurysm or cranial base neoplasm and patients with Moyamoya-angiopahty have 
been excluded from this study. All patients underwent conventional 6-vessel 
angiography for presurgical diagnostics (Figure 1). For evaluation of regional cerebral 
blood flow (rCBF) and regional cerebrovascular reserve capacity (rCVR), H215O 
positron emission tomography (PET) or 99mTc hexamethylpropylene amine oxime 
single photon emission computed tomography (SPECT) examinations using 
acetazolamide (Diamox®) loading was performed preoperatively (Figure 2).16 
Candidates for surgery had to fulfil all three criteria as shown in Table I. 
Revascularization surgery was performed between 3 weeks and 3 months after a 
minor stroke, since surgery before 3 weeks after a stroke has been reported to have 
higher risk of bleeding on revascularization and the period 3-6 months after a stroke 
is considered to be a frequent stroke recurrence period.17 The number and 
localization of bypasses depended on the result of the PET or SPECT examination 
and angiography. Bypass surgery was performed after the method described in detail 
elsewhere.3 All patients received 300 mg acetylsalicylic acid (Aspirin cardio®) per 
day postoperatively.  
EC-IC bypass procedure: Under general anaesthesia, the head was fixed with Mayfield apparatus 
so that the plane of the squama temporalis came on the top as horizontal plane. After shaving, the 
running course of the parietal branch and/or frontal branch of the superficial temporal artery (STA) was 
identified under the guidance of Doppler sonography. The STA was dissected in the skin flap after 
reflection of a question mark incision, or it was dissected under the linear incision, in a length of 8-10 
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cm. The arterial dissection was done including periadventitial tissues. After cutting the temporal 
musculature along its muscle fiber, the squama temporalis was exposed. The centre of the craniotomy 
was placed at the point of ca. 6 cm cranial to the porus acusticus externus. This point is supposed to 
correspond with the end of the Sylvian fissure, from which branches of the middle cerebral artery 
(MCA) of ca. 1mm in diameter emerge onto the cortical surface. One burr hole was placed just caudal 
to the sutura squamosa and a small bone flap of around 3 cm diameter was sawed out towards 
cranial. After the opening of the dura and arachnoidea, one of the cortical arteries of around 1 mm in 
diameter was dissected in a length of 1cm coagulating and cutting several tiny branches of the artery. 
A rubber dam was inserted between the cortical surface and the dissected segment of the cortical 
artery for the isolation of the latter. The segment was closed with mini temporary clips and an elliptical 
arteriotomy in a length of 1.0-1.5 mm was performed. The cut end of the already dissected STA was 
brought on to the recipient artery. After its temporary proximal occlusion and irrigation of the lumen 
with heparin solution, the periadventitia was peeled off at its distal end. The end was cut so that the 
diagonal diameter corresponded with the opening of the recipient artery. An end-to-side anastomosis 
was accomplished with 8 interrupted sutures with 10-0 monofilament nylon thread. After completion of 
the anastomosis, the temporary clips and rubber dam were removed, and the patency was checked by 
micro-Doppler. After application of cellulose-gauze (Tabotamp®) around the suture line, the dura was 
approximated and closed. Compression or stenosis of the donor STA was avoided at the time of bone 
replacement, muscle-fascia and skin closure.  
In general, patients were followed-up after 3 month with an angiography and 
Doppler-ultrasound for bypass patency and then in a yearly basis in the outpatient 
clinic with neurological examination and Doppler ultrasound. The majority of patients 
had a postoperative PET or SPECT to document changes in cerebral 
haemodynamics after 3-6 month. Clinical outcome was assessed by an outcome 
scale as shown in Table II. Data are given as mean ± standard deviation (SD). 
Numeric variables were analyzed by the independent t-test and nominal variables by 
the Fisher’s exact test. A P-value < 0.05 was regarded as statistically significant. 
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Results 
 
A total of 86 STA-MCA bypass-procedures in 84 surgical sessions were performed 
in 72 patients. The female to male ratio was 1:1.8 and the mean age of all patients 
was 63 ± 10 years (range 44-82 years). Preoperatively, 44 patients (61%) presented 
with minor stroke and the remaining 28 (39%) patients presented with recurrent 
transient ischemic attacks (TIAs). Angiographic lesions for which the indication for 
surgery was made were as following: unilateral internal carotid artery (ICA) occlusion 
in 72%, bilateral ICA stenosis or occlusion in 15%, unilateral ICA stenosis in 7%, 
unilateral MCA occlusion or stenosis in 3% and other multiple bilateral 
stenosis/occlusion in 3% of cases. Patient’s characteristics are shown in Table III. 
Preoperative PET imaging was done in 48 patients and SPECT in the remaining 24 
patients for haemodynamic evaluation. All patients showed haemodynamic 
impairment in terms of reduced rCBF and rCVR. Unilateral bypass procedure was 
performed in 58 patients, in one patient two STA-MCA bypasses were performed for 
one hemisphere (using as well the anterior as the parietal branch of the STA), in 
another patient bilateral bypass procedure was performed in one surgical session, 
and the remaining 12 patients had bilateral bypass procedures with one surgical 
session per side. In case of bilateral bypass procedure, the “worse” hemisphere 
based on the clinical and radiological presentation was done first. Postoperatively 68 
patients (100%) were followed up for a mean of 34 months (range 3-165 months) and 
4 patients were lost for follow-up. Overall major ipsilateral stroke occurred in 6 
patients (9%) within the follow-up period, 4 (6%) of them occurred within 3-6 month 
after surgery. One patient with previously undetected patent foramen ovale (PFO) 
developed severe pulmonary embolism and paradox embolism leading to an 
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ipsilateral stroke. Another patient with known chronic atrial fibrillation suffered from a 
traumatic brain injury later on, leading to a discontinuation of the coumarine 
medication. Thereafter the patient suffered from an ipsilateral stroke, most probably 
due to cardioembolic stroke. In further 2 patients, major stoke occurred few days 
after discontinuation of the Aspirin medication. In both patients, medication was 
discontinued for elective general surgical procedures: In one patient for a lung biopsy 
and in the other for a laparoscopic cholecystectomy. Ipsilateral minor stroke occurred 
in 4 patients (6%) within the follow-up period, all within 3-6 months after surgery. 
Recurrent TIAs occurred in 2 patients (3%). Concerning the outcome, 52 patients 
(77%) had a good outcome, 6 patients (9%) had a fair outcome, 5 patients (7%) had 
worse outcome and the remaining 5 patients (7%) were identified as dead. All 
patients with worse outcome had a major stroke postoperatively. Death by stroke 
occurred in one patient. The causes of death in the remaining 4 patients were as 
following: 1) Postoperative myocardial infarction 2) Postoperative intracerebral 
haemorrhage due to a hypertensive crisis 3) Fatal complication of a contralateral 
carotid endarterectomy weeks later on 4) Renal failure months later on. Age, gender 
or type of preoperative ischemic event was not associated with adverse outcome 
(Table IV). The postoperative patency was clearly verified in 65 bypasses (81%) 
(Figure 1), 2 bypasses (3%) were not patent and in the remaining 13 bypasses 
(15%), patency could not be clearly established and were classified as questionable 
patent. Patients with not patent or questionable patent bypasses had more stroke or 
recurrent TIAs, however without statistical significance (P = 0.15 Fisher’s exact test). 
Bypass patency was documented up to 165 month after surgery. Postoperative 
haemodynamic evaluation was performed in 33 patients with 39 revascularized 
hemispheres by PET and in 13 patients with 14 hemispheres by SPECT (Figure 2). 
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Cerebral haemodynamics were improved in 43 (81%) hemispheres and unchanged 
or worse in 10 (19%) hemispheres. Patients with unchanged or worse cerebral 
haemodynamics had significantly more often postoperative stroke or recurrent TIAs 
(P = 0.04 Fisher’s exact test).  
 
 
Discussion 
 
In the current retrospective analysis of prospectively collected data, patients with 
reduced cerebral haemodynamics in terms of reduced rCVR and rCBF had an overall 
(i.e. minor and major) stroke risk of 15% during the follow-up period, resulting in an 
annual risk of 5% per year. The overall mortality was 7%. Death by stroke occurred in 
one patient (<2%). The major flaws of the present study are certainly its retrospective 
nature and the lack of a control group. Further, postoperative haemodynamic 
evaluation was available in a majority of patients but not in all.  
Reviewing the existing literature, patients with compromised cerebral 
haemodynamics seem to have a higher risk of subsequent stroke when treated 
medically.18-21 Assessment of cerebral haemodynamics can be performed by a 
variety of different methods with different protocols. The quality of evidence 
concerning the stroke prediction is variable. Among them, measurement of oxygen 
extraction fraction (OEF) by PET and CVR assessment using acetazolamide 
administration by PET or SPECT, are most frequently reported and probably most 
accurate. Klijn et al. reported, from a review of the literature, that patients with 
impaired haemodynamics of any severity have a combined annual risk of ipsilateral 
stroke of 10%, and patients with severely impaired haemodynamics have an annual 
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risk of 31%.20 More recent studies from Japan revealed an annual ispilateral stroke 
risk of 17% and 24% in patients with decreased rCVR.18, 21 Although a direct 
comparison with the current study is difficult due to methodological reasons, the 
current results indicate a beneficial effect of the bypass procedure for patients with 
haemodynamic impairment in terms of stroke prevention by improved cerebral 
haemodynamics in concordance with previous reports.13, 14, 22-25 One has to consider 
the racial differences in the distribution of steno-occlusive lesions, which might 
present with different stroke risk and also different risk-reduction by EC-IC bypass 
procedure.26, 27 It is noteworthy that in the international EC-IC bypass study a 
Japanese-Asian subgroup mainly consisting of MCA occlusive lesions showed less 
incidence of stroke recurrence in the surgical group though of no decisive statistical 
significance.28 In the present study, the patient population consisted of manly 
Caucasians with ICA lesions (Table III). Bilateral lesions with correlating clinical and 
haemodynamic features were present in 13 patients (18%). Further, in up to 1/3 of 57 
patients (79%) with unilateral steno-occlusive lesions of the ICA had at least one 
additional stenosis or hypoplasia of the contralateral ICA or posterior circulation 
vessels. In these patients, the additional lesion did neither cause correlating 
symptoms nor haemodynamic impairment per se. However it can be assumed, that 
the additional lesions contributed to the territorial haemodynamic impairment of the 
main steno-occlusive vessel in terms of poor collateralisation. 
In the international EC-IC bypass study, the aspect of haemodynamic impairment 
has not been considered, as the methodology was immature and also not prevalent. 
Until today no randomized trial has been carried out to proof the superiority of bypass 
surgery in patients with compromised haemodynamics in terms of stroke prevention. 
To address this question, two randomized controlled clinical trials of EC-IC bypass in 
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patients with atherosclerotic carotid artery occlusion using haemodynamic criteria for 
patient selection are in progress: The Japanese EC-IC Bypass Trial (JET-Study) has 
completed its enrolment (206 patients in 29 centres). Patients in the surgical group 
showed a statistically significant decrease in stroke occurrence.29 The Carotid 
Occlusion Surgery Study (COSS) is currently enrolling patients in North America. 
Patients with unilateral internal carotid artery occlusion who have had ipsilateral 
hemispheric symptoms within 120 days are eligible to undergo PET measurements 
to determine if they qualify (http://www.cosstrial.org).7 These studies might 
definitively confirm that the conclusions of the international EC-IC bypass trial may 
not be applicable to the subset of patients with impaired haemodynamics.  
“Cardioembolism” is defined as one of the exclusion criteria in the JET-Study.30 
For COSS, “known heart disease likely to cause cerebral ischemia” are listed as 
exclusion criteria. However atrial fibrillation, PFO and atrial septal aneurysm are per 
se not listed as exclusion criteria (http://www.cosstrial.org).7 In the present case 
series each one patient had adverse outcome by stoke due to a PFO and atrial 
fibrillation. In case patients have potential cardio-embolic risks beside cerebral 
haemodynamic impairment, the indication of EC-IC bypass should be considered 
carefully since risk reduction for subsequent stroke might be lower. 
In two patients major ipsilateral stoke occurred after discontinuation of Aspirin for 
elective surgical procedures, a lung biopsy and a laparoscopic cholecystectomy. 
Since withdrawal of Aspirin medication is associated with an estimated risk of 10% 
for all vascular events, the current recommendation is to maintain Aspirin if possible 
throughout the perioperative period.31 Based on the present results, Aspirin should 
not be stopped for elective surgery in patients with history of EC-IC bypass, 
whenever possible.  
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Because EC-IC bypass is a surgically challenging procedure, the average 
cumulative experience contributes to outcome over time. This surgical procedure is 
reported to have a particularly steep learning curve as documented by Sundt et al..32 
According to their experience, up to 20 bypass procedures were mandatory to reach 
a constant patency rate over 90%. In a population-based study, Amin-Hajani et al. 
found that 1/3 of bypasses in the US were performed in “lower-volume” centres with 
less than one operation yearly.33 The more, an increased risk of adverse outcome at 
discharge from a “lower-volume” centre after any EC-IC bypass procedure in the US 
was found. Therefore he concluded that due to the low caseloads, referral of patients 
who require EC-IC bypass to a small number of “high-volume” centres might improve 
outcome and help to maintain the technical surgical skills. At the Department of 
Neurosurgery, University Hospital Zurich, a total of 327 EC-IC bypass procedures in 
265 patients were performed in a 14 years period, about each 1/3 for atherosclerotic 
occlusive disease, Moyamoya-angiopathy and therapeutic occlusion of intracranial 
arteries for unclippable aneurysm or cranial base neoplasm. It can be assumed, that 
in this time period, the caseload was one of the highest in Switzerland. Nevertheless 
complications and adverse outcome were present in the current case series. Since 
patients with atherosclerotic occlusive disease are often polymorbid, experienced 
overall perioperative patient management is mandatory beside the technical surgical 
skills for bypass procedure. Therefore “pooling” of EC-IC bypass procedures in 
determined centres is of interest to gain and maintain not only surgical skills but also 
overall perioperative management. 
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Conclusions 
 
The results of this single centre study show the feasibility of EC-IC bypass 
procedure in selected patients with occlusive cerebrovascular disease and 
haemodynamic impairment in terms of reduced rCVR and rCBF. The overall annual 
risk for ipsilateral stroke was 5% per year. Compared to previously described stroke 
risk in natural history of patients with compromised haemodynamics, the current 
results indicate a risk reduction by EC-IC bypass surgery. In patients with EC-IC 
bypass, a maximum of effort is needed to avoid any perioperative cardio-vascular 
complications.  
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Figure legends 
 
Figure 1. Preoperative Angiography, anterior-posterior (A) and oblique view (B), 
shows a complete occlusion of the right ICA (arrow). Postoperative angiography, 
antererior-posterior view (A) and lateral view (B), shows a filling of the distal braches 
of right MCA (arrowhead) by a patent bypass (arrow) via the right STA. 
 
Figure 2. Upper 2 rows show preoperative H215O PET images with a decreased 
baseline CBF and decreased reactivity on acetazolamide (Diamox®) in the right 
hemisphere. The lower two rows show postoperative H215O PET images with an 
increase as well in baseline CBF as in acetazolamide-reactivity in the parieto-
temporal region of the right hemisphere. 
 
 
Table I  
 
Indication criteria of the STA-MCA bypass 
 
 
1. Clinical  Recurrent TIAs or minor stroke with no or minor neurological 
deficits 
  
2. Angiography a) MCA-M1 occlusion or stenosis (> 50%) 
  b) ICA occlusion 
  c) ICA stenosis (> 50%) above the mandibulomastoid line 
  
3. PET/SPECT Haemodynamic compromise with reduced rCVR and reduced 
baseline rCBF 
 
 
TIA: transient ischemic attack, MCA: middle cerebral artery, ICA: internal carotid 
artery, rCVR: regional cerebrovascular reserve capacity, rCBF: regional cerebral 
blood flow. 
 
 
Table II 
 
Outcome Scale 
 
 
 Good - neither major nor minor strokes occur 
- no worsening or improvement of any preoperative deficit 
 
 
 
 Fair - further minor stroke or recurrent TIAs occur 
- no worsening of any preoperative deficit 
 
 
 Worse - further major stroke occur 
- worsening of any preoperative neurological deficit  
 
 
 Dead - patient died due to perioperative complications or due to 
other reasons 
 
 
 
Table III 
 
Patientʼs characteristics 
 
 
Age (years ± SD) 63  ± 10 
  
Gender (n)  
 Male 46  (64%) 
 Female 26  (36%) 
  
Preoperative symptom (n (%))  
 TIAs 28  (39%) 
 Minor stroke 44  (61%) 
  
Most distal angiographic lesion* (n (%))  
 ICA occlusion 52 (72%) 
 ICA stenosis 5 (7%) 
 MCA stenosis/occlusion 2 (3%) 
 Bilateral ICA stenosis/occlusion 11 (15%) 
 Bilateral MCA stenosis/occlusion 1 } (3%)  ICA occlusion, contralateral MCA stenosis 1 
 
 
SD: standard deviaton, TIA: transient ischemic attack, ICA: internal 
carotid artery, MCA: middle cerebral artery, *refers to the most distal 
angiographic lesion for which the indication for surgery was given. 	  
Table IV 
 
Dichotomized outcome in relation to baseline characteristics 
 
 
 Outcome 
    
 good/fair  worse/dead 
 (n = 58)  (n = 10) 
    
    
Age (years ± SD) 62.3 ± 9.2 ns* 63.2 ± 10.9 
    
Gender (female:male) 1:1.42 ns** 1:9 
    
Preoperative symptom 1:1.32 ns** 1:2.3 (minor stroke:TIAs) 
 
 
SD indicates standard deviation; TIA, transient ischemic attack; ns, statistically not 
significant; *independent t-test; **Fisher’s exact test. 
 


